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Abstract
Background: Studies suggest a paucity of and lack of prioritization in mental health research
output from low- and middle-income (LAMI) countries.
Aims: To investigate research priorities in mental health among researchers and other
stakeholders in LAMI countries.
Method: A two-stage design that included enumeration (through literature searches and snowball
technique) of researchers and stakeholders in 114 countries of Africa, Asia and Latin America and
the Caribbean; and a mail survey on priority research.
Results: The study revealed broad agreement between researchers and stakeholders and across
regions regarding the priorities for mental health research, however, stakeholders did not consider
researchers’ personal interest as an important criterion for prioritizing research. Studies on
epidemiology (burden and risk factors), health systems, and social science were the highest ranked
types of needed research. The three prioritized disorders were depression/anxiety, substance use
disorders, and psychoses, while prioritized population groups were children and adolescents,
women, and persons exposed to violence/trauma. Important criteria for prioritizing research were
burden of disease, social justice, and availability of funds. Researchers’ and stakeholders’
priorities were largely consistent with burden of disease estimates (however, suicide was under-
prioritized) and partly congruent with the research projects of the responding researchers.
Conclusions: The broad agreement found between a large and reasonably representative group of
active researchers and stakeholders provides a basis for generating policy and service relevant
evidence for global mental health.
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Introduction
Health research can contribute to advancement of science, provision of solutions for health
problems and to growth, development, equity, global security and the fight against poverty.1,2
Unfortunately, health research is beset with the ’10/90 gap.3-6 The paucity of and the geographic
variation in mental health research output,7-11 is compounded by the fact that mental health
research in low- and middle-income (LAMI) countries often does not address priority issues
suggested by needs or recommended by national institutions.12,13 This is a serious lacuna because
prioritization of mental health research is a critical component in the process of scaling up of
services for mental health.2,14
Until recently, the dominant model of research priority setting was driven by criteria such as
novelty of proposed research, attractiveness of research results and potential for publication in
high-impact journals, interests of donors and advocacy groups, individual biases of the members
of policy-making panels, and media exposure.15,16 Two types of explicit methods for priority
setting – based on indicators of needs (e.g. burden) and values (opinion of experts/stakeholders)
have been detailed.16,17 However, composite indicators of need have gained prominence in the
research priority-setting process because these measures, e.g. disability adjusted life-years
(DALY) lend themselves to comparisons across a broad range of diseases and economic analyses
of interventions.18 Although such indicators are useful for rational resource allocation,
involvement of a wide range of stakeholders is considered essential for ensuring legitimacy and
fairness of the priority setting decisions in health research investments.19,20 Participation of a
broad spectrum of stakeholders helps to identify research needs, technical and financial
capabilities, information gaps and distortions, the political environment, and the values and ethics
of a given society; and it fosters ownership of the process and output of priority setting initiatives,
and facilitates shared responsibility and accountability in the implementation of the research
agenda.19,21,22
During the past decade, a number of LAMI countries have conducted priority setting exercises
that have successfully involved stakeholders to identify priority research issues in health, health
systems and health policy.22 However; these have mostly involved single countries and have not
addressed priorities in mental health research. The present study was undertaken to address the
lack of evidence concerning global and regional stakeholder priorities in mental health research in
LAMI countries.
Methods
The survey questions reported on here were part of a larger study "Mental Health: Mapping of
Research Capacity in Low- and Middle-Income Countries" that aimed to develop regional maps
of mental health researchers, and detail their research agenda and the research infrastructure
(institutional, funding, policy on research, etc.) that supports them.23 This is the first article from
that study and it is based on the section on priorities for mental health research.
The Global Forum issued a "Request for Proposals" that was distributed widely through a
combination of electronic and postal methods to universities, research institutions and individuals
in LAMI countries of Africa, Asia and Latin America and the Caribbean (henceforth termed the
Americas). LAMI countries of Europe and the Middle East were not included. Six out of 18
distinct proposals (two from each region) were selected based on their scope (the extent to which
they met the broad goals of the project) and the capabilities of the teams. Further project
development occurred with coordination and support from Global Forum and World Health
Organization (WHO), so the six teams addressed some common issues. A standardization
workshop with project leaders (Global Forum, WHO and the six principal investigators) was
conducted to agree on the common issues and the methods to approach them, e.g. the databases to
be used, the time frame for the search for the enumeration of researchers, the documents and
networks to be tapped to enumerate stakeholders, a shared understanding of terms and definitions
use to help the teams in supporting their members and respondents who sought clarifications. A
total of 114 LAMI countries from Africa (52), the Americas (30) and Asia (32) constituted the
study universe (see Sharan et al, for the list of countries).23
Researchers were enumerated through a search of indexed (Medline and PsycInfo) and non-
indexed literature (regional databases, online journals, other local journals, unpublished papers,
presentations, and reports) for a 5-year period (1999 to 2003) for mega countries (population >100
million) and for a 10-year period (1993 to 2003) for less populated countries. All authors whose
addresses could be identified in the literature search were invited by mail or e-mail to participate
in this survey. Stakeholders were identified through websites and reports of organizations and
associations, journals, regional databases, grey literature searches, ministries of health documents
and snowball technique. Stakeholders included: (i) decision makers (legislators and officers of
ministries of health, health insurance agencies, foundations, and research councils), (ii) university
administrators, and (iii) officers of associations (office bearers of professionals associations, non-
governmental organizations, and associations of users and carers). Survey respondents’ addresses
were obtained through local directories (e.g., professional organizations), resources like Google™
Scholar, and correspondence with affiliated institutions and colleagues.
The overall design of the postal survey was as follows: a letter of announcement was sent to
explain the rationale of the study, and inform potential respondents about availability of choice in
response formats (electronic- or paper-based) and confidentiality. One week later the
questionnaire and a pre-addressed return envelope or information about the website where the
questionnaire was available was sent. Non-respondents were sent up to four reminders (including
a copy of the questionnaire) at 2-4 weeks intervals. The questionnaires could be answered in
English or other international languages.
The draft questionnaire was developed by a core group (public health professionals of WHO and
Global Forum with knowledge of mental health, health research priority setting, and health
economics; and experience of working in and for LAMI countries) that compiled an initial list of
items within the broad health research system framework.24 The options related to questions on
priority were adapted from various sources: an unpublished WHO questionnaire on mental health
research (critiqued by 12 public mental health experts from WHO, LAMI and high-income
countries); a WHO-Research Policy and Cooperation study on health research in LAMI
countries,3 and an Australian study on research priorities in mental health.16 This questionnaire
was discussed in detail in the standardization meeting by the regional principal investigators
(mental health professionals from diverse backgrounds with extensive experience of working in
LAMI and high-income countries) who identified omitted issues and finalized the questionnaire.
The section on mental health research priorities began with the question -- “Over the next 5 years,
what in your opinion are the most important mental health research priorities in your country?”
Respondents were requested to indicate the top three for each of the following categories of
research priorities by marking multiple choice boxes:
Type of mental health research: Epidemiological studies of burden and risk factors; health
systems research (e.g., services evaluation, policy and economic studies); social science research
(e.g., illness beliefs, measurement); clinical trials; and basic sciences research (e.g., genetics and
neuro-imaging).
Mental disorders/conditions: Depression/anxiety, substance use disorders, psychoses, disorders
with onset in childhood and adolescence, suicide, dementia, personality disorders, learning
disorders, epilepsy, eating disorders, others.
Specific populations: Children and adolescents, women, persons exposed to violence/trauma, the
poor, elderly persons, disabled persons, minorities, refugees, prisoners, others.
Criteria for prioritizing: Burden of disease in the population, availability of funds, researchers’
personal interests, policy-maker request, social justice/equity and others.
The findings of the study with compared with two external (hard) indices that were available for
the same countries: projects conducted by responding researchers,23 and the burden of
neuropsychiatric diseases.25 As a part of the larger study (Mental Health: Mapping of Research
Capacity in Low- and Middle-Income Countries) each researcher had to tick multiple choice
boxes (with the same response options as in the survey on priorities) regarding the type of
research, its focus on disorders and specific populations, and the motivation(s) for conducting the
research; for three research projects carried out in the last 5 years (n=1847 projects).23 Though
questions on the project preceded those on priorities, it was possible that researchers might have
selectively reported projects that matched their subjective priorities. To check on this possibility,
we compared the ranking of various response categories in the projects with the ranking of similar
categories in indexed publications (Pubmed and PsycInfo, n=2397) from the same countries in
one region (the Americas).23 The ranking for types of research, disorders, and specific populations
was found to be identical (data available from the authors on request); suggesting that researchers
had been reasonably objective in reporting on their projects.
The table on estimated total disability adjusted life years by cause and member states (December
2004 estimates) was used to compile the burden of 6 relevant neuropsychiatric categories for 111
of the 114 countries:  depression/anxiety (unipolar depressive disorders, post-traumatic stress
disorder, obsessive-compulsive disorder, panic disorder), substance use disorders (alcohol use
disorders, drug use disorders), self-inflicted injury (including suicide), psychosis (schizophrenia),
dementia (Alzheimer and other dementias), and epilepsy.25 
The study methodology was approved by the Institutional Review Boards of the respective teams.
No formal ethical approval was required in the Philippines because the ’Official and Formal
Ethical Board’ was not in existence during the conduct of the study. A formal ethical approval
was also not required in Nigeria at the time of the study.
Results
No mental health researcher was identified in 31 of the 114 (27.2%) countries and fewer than six
researchers were identified in another 26 countries (22.8%). Almost one third of the 4633
identified mental health researchers resided in China, India and Brazil. The overall response rate
was 21.1% (Africa: 34.2%, Asia: 13.3%, the Americas: 31%) and responses were received from
researchers residing in 53 countries (46.5% of 114 countries and 71.9% of countries with more
than 5 identified researchers). The largest number of responses was received from Brazil (227)
and India (125). Three fifths of respondents were male. The average age of respondents was
45.4±9.5 years. All major disciplines of mental health (psychiatry 47%, nursing 18.3%,
psychology 12.4%, social sciences 8.6%, neurology and other medical disciplines 12.4%, public
health 3.9%) and institutional affiliations (government/ministry 56.7%, private sector 30%,
universities 22.3%, research organizations 12.2%, non government sector 7.3%) were represented
(multiple responses were permitted).
No stakeholder was identified in 22 (19.3%) countries. A total of 3829 stakeholders were
identified (decision makers 22%; association officers 49%; university administrators 29%). The
overall response rate for the stakeholder group was 10.1% (Africa 12.8%; Asia 8.9%, the
Americas 12%). Decision makers from 31 countries (27.2%), university administrators from 24
countries (21.1%) and association officers from 37 countries (32.5%) responded. Stakeholders
from the following countries formed more than 10% of the total pool of respondents in each
stakeholder group: decision makers - Brazil (17.1%) and Peru (10.5%); university administrators -
Brazil (12%) and Colombia (12%); and association officers - Philippines (18%) and India (17%).
Tables 1 to 4 show the percentage of the sample of researchers and stakeholders which rated
various response options as among the top three in priority. In addition, each of these tables show
the percentage of research projects (conducted by the responding researchers) that were related to
the same response categories as the subjective priorities.
Comparison between stated priorities of researchers and stakeholders
At the global level, researchers and stakeholders were consistent in their ranking of research
priorities by type of research. They considered epidemiological studies of burden and risk factors
the most important type followed by health systems research, social science research, clinical
trials, and basic science research (see Table 1). A 2-position (or greater) difference in ranks
between researchers’ and stakeholders’ opinion was observed for 1 out of 15 intra-regional (in
Africa) and 2 out of 30 inter-regional (both between stakeholders) comparisons.
|Table 1 about here                                                       |
The ranking of research priorities in terms of types of mental disorders was also largely consistent
across the researcher and stakeholder groups at the global level (see Table 2). Depression/anxiety,
substance use disorders, psychosis, and disorders with onset in childhood and adolescence held
the first four positions. A 2-position (or greater) difference in ranks was observed for two
conditions at the global level; 7 out of 30 intra-regional (3 each in Africa and the Americas, and 1
in Asia) and 17 out of 60 inter-regional comparisons (7 for researchers and 10 for stakeholders).
None of these differences were regarding the top four ranked conditions. Large intra-regional
differences (3-position or greater) between researchers and stakeholders were noted for suicide
(researchers gave it a higher rank in Africa and stakeholders gave it a higher rank in the Americas)
and dementia (researchers gave it a higher rank in the Americas; however the percentage
difference between the groups was small). Large inter-regional differences were noted for suicide
(researchers in the Americas and stakeholders in Africa gave it a low rank), dementia (researchers
in Africa and stakeholders in the Americas gave it a low rank), personality issues (stakeholders in
Asia gave it a low rank) and epilepsy (stakeholders in Africa gave it a high rank).
|Table 2 about here                                                       |
As Table 3 indicates, researcher and stakeholder groups were again largely consistent in their
ranking of research priorities in terms of specific populations at the global level.  Children and
adolescents, women, persons exposed to violence/trauma, the poor and the elderly were
considered the top five priorities. A 2-position (or greater) difference in ranks was observed for 6
out of 27 intra-regional (1 in Africa, 2 in Asia and 3 in Latin America) and 20 out of 54 inter-
regional comparisons (6 for researchers and 14 for stakeholders). Large intra-regional differences
(3-point or more) in ranks between researchers and stakeholders were noted for persons affected
by violence/ trauma in Asia (stakeholders gave it a higher rank). Large inter-regional differences
were noted for persons affected by violence/ trauma (researchers in Asia gave it a low rank) and
disability (stakeholders in the Americas gave it a low rank).
|Table 3 about here                                                       |
Finally, four of the five criteria for prioritizing mental health research were ranked in a similar
order by researchers and stakeholders at the global level: burden of disease, social justice,
availability of funds, and specific requests made by policy-makers’ (see Table 4). A 2-position (or
greater) difference in ranks was observed for 5 out of 15 intra-regional comparisons (2 each in
Africa and Asia and 1 in the Americas) but none of the 30 inter-regional comparisons.
Researchers and stakeholders differed markedly in the rank accorded to researchers’ personal
interest at the global level (researchers: second rank, stakeholders: fifth rank) and in each region. 
|Table 4 about here                                                                    |
Comparison with external indices
Research projects conducted by researchers
At the global level a 2-position (or greater) difference in ranks between researchers’ priorities and
research projects; and stakeholders’ priorities and research projects was observed for none of the
10 comparisons for types of research, 7 out of 20 comparisons for disorders (3 for researchers, 4
for stakeholders), 10 out of 18 comparisons for specific populations (5 each for researchers and
stakeholders), and 1 out of 8 comparisons for criteria for prioritizing research (1 for stakeholders)
(Tables 1-4). A 2-position difference in ranks was not observed for the disorders and specific
populations that received high (first three) or low (last two) ranks. A large (3-position or greater)
difference in ranks was observed for dementia (lower rank in stakeholders’ opinion in comparison
to research projects), personality issues (higher rank in researchers’ opinion in comparison to
research projects) and learning disorders (higher rank in researchers’ opinion in comparison to
research projects) (Table 2); persons affected by poverty (higher rank in researchers’ and
stakeholders’ opinions in comparison to research projects) (Table 3), and personal interest of
researchers as a criterion for prioritizing research (lower rank in stakeholders’ opinion in
comparison to research projects) (Table 4).
In intra-regional comparisons, a 2-pointsition (or greater) difference in ranks was observed for 1
out of 30 comparisons for types of research (1 for researchers), 12 out of 60 comparisons for
disorders (5 for researchers, 7 for stakeholders), 24 out of 54 comparisons for specific populations
(11 for researchers, 13 for stakeholders), and 6 out of 24 comparisons for criteria for prioritizing
research (1 for researchers and 5 for stakeholders) (Table 1-4).  A 3-position (or greater)
difference in ranks in comparison to projects was observed for research on suicide in Africa
(lower rank in stakeholders’ opinion in comparison to research projects); personality issues in
Asia (lower rank in stakeholders’ opinion in comparison to research projects), and suicide (lower
rank in researchers’ opinion in comparison to research projects), dementia (lower rank in
stakeholders’ opinion in comparison to research projects) and learning disorders (higher rank in
researchers’ and stakeholders’ opinion in comparison to research projects) in the Americas (Table
2). A 3-position (or greater) difference in ranks was also observed for research on persons affected
by poverty (higher rank in researchers’ and stakeholders’ opinion in comparison to research
projects) and minorities (lower rank in researchers’ and stakeholders’ opinion in comparison to
research projects) in Africa; persons affected by violence / trauma (higher rank in stakeholders’
opinion in comparison to research projects), poor (higher rank in researchers’ and stakeholders’
opinion in comparison to research projects), elderly (higher rank in researchers’ opinion in
comparison to research projects), disabled (lower rank in researchers’ and stakeholders’ opinion in
comparison to research projects), minorities (lower rank in stakeholders’ opinion in comparison to
research projects), and prisoners (lower rank in stakeholders’ opinion in comparison to research
projects) in Asia; and the poor (higher rank in researchers’ and stakeholders’ opinion in
comparison to research projects) and disabled (lower rank in stakeholders’ opinion in comparison
to research projects) in the Americas. A difference of similar magnitude was also observed for
personal interest of researchers as a criterion for prioritizing research (lower rank in stakeholders’
opinion in comparison to research projects) in Asia and the Americas.
Burden of neuropsychiatric diseases
A comparison of researchers’ and stakeholders’ opinion on research priorities with burden of
disease estimates for the concerned countries showed a broad similarity in ranking (Table 5). At
the global level, a 2-position difference in ranking was seen for suicide and dementia with the
researchers ranking the former lower and the latter higher than their respective ranks according to
burden of disease estimates. However, the percent difference between researchers and
stakeholders was small in the case of dementia. A 2-position difference in ranks was observed for
8 out of 36 comparisons at the intra-regional level.
|Table 5 about here                                                       |
Discussion
Global mental health research priorities
The study revealed broad agreement between researchers and stakeholders and across regions
regarding the priorities for mental health research in LAMI countries. The three highest ranked
types of research were: epidemiological studies of burden and risk factors, health systems
research, and social science research. The three priority mental disorders/conditions were
depression/anxiety, substance use disorders, and psychoses, and the three population groups that
were prioritized were children and adolescents, women, and persons exposed to violence/trauma.
The three highest ranked criteria for prioritizing research were burden of disease, social justice
and availability of funds. The similarities found in priorities between researchers and stakeholders
and across regions raise genuine hopes of making research an instrument for change via
collaboration among LAMI countries, researchers and stakeholders.
Researchers and stakeholders accorded epidemiological studies of burden and risk factors and
health systems research the highest ranks on types of needed research. Eight of the 12 research
options that received the highest priority scores from the Lancet Global Mental Health Group
addressed health policy and systems research involving existing interventions and epidemiological
research to inform priority setting.14
Depression and anxiety, which cause the greatest burden among neuropsychiatric diseases,25 were
considered a priority condition by a large proportion of researchers and stakeholders. A nation-
wide survey of stakeholder perspectives on research priorities in mental health in Australia also
showed that all stakeholder groups prioritize affective disorders.16 The prioritization of substance
use disorders and schizophrenia by a large proportion of stakeholders also follows the burden of
disease estimates.25 In keeping with their burden, the Lancet Global Mental Health Group focused
on four disorders while setting priorities for global mental health research: depressive, anxiety and
other common mental disorders; alcohol- and other substance-abuse disorders; child and
adolescent mental disorders; and schizophrenia and other psychotic disorders.14 Compared to their
burden, suicide was under-prioritized and dementia was ‘over’-prioritized, especially by
researchers. Suicide appeared to be similarly under-prioritized in a previous audit of mental health
research publications from LAMI countries.13
Despite differences in definition of population subgroups, children and adolescents and the
socially and economically disadvantaged were consistently rated highly by all stakeholder groups
in the Australian survey on stakeholder perspectives.16 The prioritization of women in this study
may reflect their greater risk for the highly prevalent and burdensome depressive and anxiety
disorders,25,26 as well as their disadvantaged status with regard to men. Many international
organizations have stressed the need for gender-mainstreaming in research.3,21
In the present study, the most salient difference between researchers and stakeholders was in the
importance accorded to personal interest of researchers as a criterion for prioritizing research.
Experts in research governance suggest that ideological emphasis on ‘scientific autonomy’ in the
process of research agenda setting has been largely responsible for the lack of public health and
operational emphasis in research agenda; and support the use of a systematic and transparent
process of priority setting to ensure that the voice and will of the different stakeholders are heard
and respected.1,3,14-21 The finding of higher ranking of burden of disease in comparison to social
justice as criteria for prioritization of research in the present study is similar to the greater
emphasis on  disease burden in comparison to equity seen in an audit of projects on health policy
and systems research in LAMI countries.27 The very low rank accorded to policy-maker request
by both researchers and stakeholders can be problematic because strategically integrating research
into the health system functions of stewardship and service delivery facilitates government
support for research.28
Researchers’ and stakeholders’ ranking of subjective priorities were similar to the ranks achieved
by similar response categories in projects conducted by researchers, particularly for types of
research and criteria for prioritization. A greater number of differences were noted for disorders
and specific populations (mainly for medium priority disorders and sub-populations), suggesting a
need for better research governance as indicated by earlier audits of presentations and publications
on mental health research from LAMI countries.12,13 Both researchers and stakeholders gave a
much higher priority to persons affected by poverty in comparison to the rank achieved by this
sub-population in research projects, suggesting that research on equity needs to be given greater
prominence.  On the other hand, both researchers and stakeholders gave a much lower priority to
prisoners in comparison to the number of projects done on this sub-population, suggesting that the
‘captive’ nature of this subpopulation makes it easier to conduct research on them. It may be
important to look into ethical aspects of the research conducted on prisoners.
In order to contextualize issues related to delineating priorities for mental health research in
LAMI countries, it would be important to remain cognizant of the many barriers to research in
poorly resourced settings with scarce financial, human and technical resources.29,30 While data on
the number of researchers and research funding in the area of mental health in LAMI countries are
not readily available, it is known that the ratio of scientists per 1000 population in developing
countries is under 0.5, in contrast to developed countries where the ratio is over 2. Similarly,
developing countries invest less than 1% of their GDP in research and development, compared to
2% in high-income countries.31 Thus, in addition to improvement in prioritization of mental health
research, efforts would be needed to increase resources (e.g. capacity and funding) available for
conducting such research in the LAMI countries.14,28,32
It also needs to be emphasized that the present study does not address the issue of the priority to
be accorded to research in relation to other activities (e.g. services) that are needed in the LAMI
country context. However, influential expert groups envision an active role for research in the
multidimensional efforts required to change the current mental health situation in these
countries.2,14 Though, the ability of national institutions in LAMI countries to produce and use
high quality health research that is appropriate to their needs can be weak at various stages of the
policy process;  scientific research informs mechanisms (e.g. media, powerful advocates) that
influence policy and public health;33,34 and  there are some good examples, where local research
findings were interpreted and utilized against a background of global evidence and experience
from different settings to change government policies in the mental health field in LAMI countries
in LAMI countries.35,36
Regional issues
Assessed in terms of ranks the concordance between the subjective priorities of researchers and
stakeholders was fairly high; and actually greater than the concordance between researchers’
subjective priorities and the ranks given to similar response categories in research projects.
Consistently higher prioritization of certain issues (e.g. learning disorders in the Americas) by
both researchers and stakeholders in comparison to the rank achieved by these in research projects
make them important for regional research governance.
While there was an overall similarity in the appreciation of need (burden of disorder) among
researchers and stakeholders, some differences in values and interest were also evident. American
stakeholders gave a lower priority to dementia in comparison to researchers and research projects.
A similar finding was reported in the Australian survey on stakeholder perspectives and the
authors suggested that stakeholders may have a lesser appreciation of the burden caused by
dementia;16 however, a discordance between researchers and stakeholders was not seen in Africa
and Asia. Similarly, African stakeholders gave a lower ranking to suicide in comparison to
researchers and research projects; however researchers in the Americas gave a lower priority to
the same condition in comparison to stakeholders. While, more research is required to understand
the reason for the differences between researchers and stakeholders and between regions;
cognizance of these differences is necessary for the process of translation of research findings into
information related to regional research governance including decisions on funding.37
There were greater inter-regional differences regarding priorities between stakeholders in
comparison to researchers, probably due to differences in appreciation of financial capabilities,
information gaps and distortions, the political environment, and the values and ethics of a given
society. Hence, eliciting stakeholders’ input would appear to be very relevant at each level (local,
national, regional, global) of priority setting.
Larger inter-regional differences in ranking were noted for disorders given lower ranks and for
many specific populations, suggesting areas where elicitation of stakeholder perspectives would
be absolutely crucial - conditions for which evidence of need (e.g. burden) are lacking or
differences in need are less salient and issues that appear to be particularly imbued with social
values in the given context(s). Significantly, there was no inter-regional variation in the criteria
for prioritization of research, which is welcome information for consensus building and working
on global priorities.
Methodological Issues
An innovative aspect of the methodology applied here was to reach out to a large and reasonably
representative group of active researchers in LAMI countries by following a two-stage design,
starting with mapping of researchers and stakeholders through both literature searches and
snowball technique, and then surveying them through six regional teams. The large number of
researchers identified in Brazil, China and India was in keeping with their population size and
recognized research capacity.7,13 As in the Australian survey of stakeholder priorities,16 relevant
stakeholders were more difficult to sample because there were few organized lists and it was
difficult for research groups (based outside the country) to identify stakeholders who were
familiar with mental health research.
Postal questionnaires are widely used to collect data in health research and appeared to be the only
financially viable option for collecting information from the large, geographically dispersed
populations addressed in this study. The study suffers from the known disadvantages of postal
questionnaires that is low response rate and consequent lack of representativeness; despite the fact
that we tried to meet most of the well-known criteria that increase response rates (use of a short
questionnaire, personalized letters, pre-contact, follow-up contact, and academic origin of the
investigation).38,39 The low response rate could be partly explained by myriad pragmatic
difficulties, e.g. difficulties in locating current contact details due to mobility of researchers;
dispersion of researchers across a range of departments; poor internet facilities and telephone and
postal services; and language barriers. However, it is also possible that issues related to saliency
of the questionnaire for the intended subjects played a role in the low response rate. Subjects
might have doubted the usefulness of the questionnaire on methodological grounds (use of forced
choice format to answer complex questions related to research priorities) or in terms of its ability
to meet its intended outcome (change in research priorities at the national/ regional/ global
level).38-40  However, the intensity and breadth of the exercise in identifying and surveying
researchers and stakeholders provides a more representative opinion on the research priorities in
mental health in LAMI countries in comparison to the opinion of a few highly selected experts
that form a part of most priority-setting efforts. This is a significant contribution of the study,
particularly because there is no previously published data on this issue.
The convergence of values in the present study should be a strong reason for paying attention to
its findings; however it is possible that the results may have been influenced by our utilization of a
ranking methodology with prefixed options, particularly for questions with few response options
e.g. types of research and criteria for prioritization. Stakeholders’ values can be directly elicited
using more sophisticated quantitative (e.g. surveys where respondents weigh or rate their values)
as well as qualitative (e.g. individual interviews, Delphi technique, group discussions, concept
mapping) methods.19 Previous transnational studies on research priorities have utilized discussion
groups,41 and content analysis of projects;27 however, these studies were conducted on much
fewer respondents or projects in comparison to the present survey. The nationwide stakeholder
survey on research priorities in mental health in Australia utilized a methodology that was similar
to our survey.16 It is important to recognize that the higher prioritization of some types of
research, disorders and specific populations mandated by the forced choice format necessarily led
to lower prioritization of others such as clinical trials; suicide, learning disabilities and dementia;
and refugees, minorities, prisoners, and those with disability. It is hoped that the ‘absence of
the latter from the priority list’ should not lead to a neglect of the already tenuous efforts to
research these major areas and subgroups with high unmet need for research (e.g. clinical trials42).
The following limitations of the survey should also be kept in mind while interpreting its results.
Identified options that were outlined in the questionnaire were not compiled through an objective
and repeatable method, but rather through consensus reached by panels of experts; and the
decisions could be seen as driven by research interest bias of these experts. Stakeholders may
have less knowledge about research opportunities in the mental health field in comparison to
researchers and some stakeholders might have had difficulty in distinguishing between priorities
for research and service provision.16 It is possible that disaggregating the stakeholder groups (e.g.,
service providers, carers) might have yielded different results. In the Australian survey, various
stakeholder groups had differing perspectives on research priorities, and major differences were
observed between committees that evaluate research grants, and consumer and carer
groups.16 Also, the questionnaire distributed to researchers in one sub-region in the Americas did
not include the item on social justice as a criterion for prioritizing mental health research, making
conclusions on this item tentative.
Implications
Mental health research as a component of health research is an essential link to equity and
development. For research priorities to serve as a basis for policy and service delivery, a major
effort is needed to ensure that all countries and institutions base their resource allocations on a
priority-setting process that is transparent, participatory and scientific. Institutions (governments,
donors, research institutions and non- and inter-governmental organizations) concerned with
promoting mental health research should use the priorities that researchers and stakeholders in
LAMI countries seem to agree upon as the basis for generating policy and service relevant
evidence for global mental health. The differences between regions should form the basis for
regional specificity in priority setting and the differences between researchers and stakeholders, as
an argument for efforts to generate broad stakeholder participation in mental health research
stewardship. The following steps may be helpful in ensuring implementation of mental health
research priorities at various levels: transformation of the broad list of research priority areas into
a research portfolio; integration of priorities into appropriate plan, agenda or policy to ensure
political backing; periodic review and update of priorities; and investment in research priorities.
|Implications                                                             |
|The similar views expressed between a large and reasonably representative|
|group of active researchers and stakeholders, and across regions;        |
|provides the common grounds for generating policy and service relevant   |
|evidence for global mental health.                                       |
|Stakeholder groups differed in the importance they gave to personal      |
|interest of researchers as a criterion for prioritizing research, a      |
|finding that underlines the utility of multiple stakeholder perspective  |
|in developing balanced priorities.                                       |
|Limitations                                                              |
|The response rate was low and the number of responses was not            |
|proportionate to the number of identified researchers and stakeholders in|
|each country.                                                            |
|The results of the survey could have been influenced by its utilization  |
|of a ranking methodology with prefixed options.                          |
|Identified options that were outlined in the questionnaire were not      |
|compiled through an objective and repeatable method, but rather through  |
|consensus reached by panels of experts.                                  |
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Table 1. Researchers’ and stakeholders’ opinion and research projects regarding mental health research
priorities: types of research (%, rank)
|Regions   |Africa                   |Asia                     |The Americas              |Global                   |
|Stakehold|Resear-chers             |Stake-holders           |Projects                 |Resear-chers              |
|er       |(N=114)                  |(N=35)                  |                         |(N=299)                   |
|Category |                         |                        |(N=267)                  |                          |
|Stakeholde|Resear-chers             |Stake-holders           |Projects                |Resear-chers             |
|r Category|(N=115)                  |(N=35)                  |                        |(N=297)                  |
|          |                         |                        |(N=263)                 |                         |
|Stakeholder|Resear-chers             |Stake-holders              |Projects                 |Resear-chers             |
|Category   |(N=114)                  |(N=35)                     |                         |(N=294)                  |
|           |                         |                           |(N=253)                  |                         |
|Stakehold|Resear-chers             |Stake-holders             |Projects                  |Resear-chers             |
|er       |(N=113)                  |(N=35)                    |                          |(N=296)                  |
|Category |                         |                          |(N=269)                   |                         |
Stakeholder Category |Resear-chers
(N=115) |Stake-holders
(N=35) |Burden of disease
 |Resear-chers
(N=297) |Stake-holders
(N=160) |Burden of disease
 |Resear-chers
(N=399) |Stake-holders
(N=102) |Burden of disease
 |Resear-chers
(N=811) |Stake-holders
(N=297) |Burden of disease
 | |Dep/ Anx |64.3 (R1) |54.3 (R2) |7983 (R1) |73.1 (R1) |74.4 (R1) |44897 (R1) |82.5 (R1) |73.5 (R1) |8326 (R1) |76.4 (R1) |71.7 (R1) |61207 (R1) | |Subs Use D |50.4
(R2) |71.4 (R1) |2599 (R2) |38.4 (R3) |59.4 (R2) |9405 (R4) |63.7 (R2) |59.8 (R2) |4919 (R2) |52.5 (R2) |60.9 (R2) |16922 (R2) | |Psychoses |37.4 (R3) |48.6 (R3) |2122
(R3) |39.7 (R2) |37.5  (R3) |9489 (R3) |42.4 (R3) |44.1 (R3) |1490 (R3) |40.7 (R3) |41.1 (R3) |13100 (R4) | |Suicide |16.5 (R4) |8.6 (R6) |1024 (R4) |29.3 (R4) |22.5 (R4)
|13847 (R2) |5.5 (R6) |20.6 (R4) |758 (R5) |15.8 (R5) |20.2 (R4) |15630 (R3) | |Dementia |10.4 (R5) |20.0 (R4) |438 (R6) |15.5 (R5) |15.6 (R5) |4048 (R5) |19.3 (R4)
|18.6 (R5) |750 (R6) |16.6 (R4) |17.2 (R5) |5236 (R6) | |Epilepsy |7.8 (R6) |17.1 (R5) |1735 (R5) |11.1 (R6) |4.4  (R6) |3622 (R6) |7.5 (R5) |9.8 (R6) |896 (R4) |8.9 (R6)
|7.7 (R6) |6254 (R5) | |
R: Rank
Dep/Anx,  Depression/anxiety; Subs Use D, Substance use disorders; Child Adol D,  Disorders with onset in
childhood and adolescence; Personality, Personality issues; Learning D, Learning disorders; Eating D, Eating
disorders.
Note: The sum for some variables is more than 100% because subjects could give multiple responses within the
same category.
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